HEADER HYDROLASE/HYDROLASE INHIBITOR 27-AUG-15 5DG6 TITLE 2.35A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE IN COMPLEX AN TITLE 2 OXADIAZOLE-BASED, CELL PERMEABLE MACROCYCLIC (21-MER) INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1101-1281; COMPND 5 EC: 3.4.22.66; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NORWALK VIRUS; SOURCE 3 ORGANISM_COMMON: HU/NV/NV/1968/US; SOURCE 4 ORGANISM_TAXID: 524364; SOURCE 5 STRAIN: GI/HUMAN/UNITED STATES/NORWALK/1968; SOURCE 6 GENE: ORF1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS PROTEASE, NOROVIRUS, NORWALK VIRUS, ANTIVIRAL INHIBITORS, OXADIAZOLE KEYWDS 2 INHIBITOR, CELL PERMEABLE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LOVELL,K.P.BATTAILE,N.MEHZABEEN,V.C.DAMALANKA,Y.KIM,K.R.ALLISTON, AUTHOR 2 P.M.WEERAWARNA,A.C.G.KANKANAMALAGE,G.H.LUSHINGTON,K.-O.CHANG, AUTHOR 3 W.C.GROUTAS REVDAT 6 12-AUG-20 5DG6 1 REMARK REVDAT 5 11-DEC-19 5DG6 1 REMARK REVDAT 4 27-SEP-17 5DG6 1 JRNL REMARK REVDAT 3 23-MAR-16 5DG6 1 JRNL REVDAT 2 17-FEB-16 5DG6 1 JRNL REVDAT 1 10-FEB-16 5DG6 0 JRNL AUTH V.C.DAMALANKA,Y.KIM,K.R.ALLISTON,P.M.WEERAWARNA, JRNL AUTH 2 A.C.GALASITI KANKANAMALAGE,G.H.LUSHINGTON,N.MEHZABEEN, JRNL AUTH 3 K.P.BATTAILE,S.LOVELL,K.O.CHANG,W.C.GROUTAS JRNL TITL OXADIAZOLE-BASED CELL PERMEABLE MACROCYCLIC TRANSITION STATE JRNL TITL 2 INHIBITORS OF NOROVIRUS 3CL PROTEASE. JRNL REF J.MED.CHEM. V. 59 1899 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26823007 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01464 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.240 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 14091 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 712 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.9043 - 4.0170 1.00 2814 160 0.1844 0.2177 REMARK 3 2 4.0170 - 3.1891 1.00 2663 147 0.1880 0.3095 REMARK 3 3 3.1891 - 2.7861 1.00 2681 123 0.2298 0.2914 REMARK 3 4 2.7861 - 2.5315 1.00 2606 147 0.2580 0.3430 REMARK 3 5 2.5315 - 2.3501 1.00 2615 135 0.2601 0.3181 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2438 REMARK 3 ANGLE : 0.918 3319 REMARK 3 CHIRALITY : 0.053 386 REMARK 3 PLANARITY : 0.007 415 REMARK 3 DIHEDRAL : 11.971 1411 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DG6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000213165. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14146 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 42.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.15100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.86800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.7 REMARK 200 STARTING MODEL: 3UR9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (W/V) PEG 2000 MME, 150 MM REMARK 280 POTASSIUM BROMIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.84300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.73550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.55650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.73550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.84300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.55650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 THR A 123 REMARK 465 GLY A 124 REMARK 465 ALA A 125 REMARK 465 ASN A 126 REMARK 465 ALA A 127 REMARK 465 LYS A 128 REMARK 465 GLY A 129 REMARK 465 MET A 130 REMARK 465 ASP A 131 REMARK 465 GLY A 174 REMARK 465 GLU A 175 REMARK 465 GLY A 176 REMARK 465 GLU A 177 REMARK 465 THR A 178 REMARK 465 ALA A 179 REMARK 465 LEU A 180 REMARK 465 GLU A 181 REMARK 465 MET B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 ILE B 109 REMARK 465 GLN B 110 REMARK 465 GLY B 111 REMARK 465 ARG B 112 REMARK 465 LEU B 113 REMARK 465 THR B 123 REMARK 465 GLY B 124 REMARK 465 ALA B 125 REMARK 465 ASN B 126 REMARK 465 ALA B 127 REMARK 465 LYS B 128 REMARK 465 GLY B 129 REMARK 465 MET B 130 REMARK 465 ASP B 131 REMARK 465 LEU B 132 REMARK 465 SER B 163 REMARK 465 GLY B 164 REMARK 465 ASN B 165 REMARK 465 GLY B 174 REMARK 465 GLU B 175 REMARK 465 GLY B 176 REMARK 465 GLU B 177 REMARK 465 THR B 178 REMARK 465 ALA B 179 REMARK 465 LEU B 180 REMARK 465 GLU B 181 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 0 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 37 CG CD CE NZ REMARK 470 GLU A 38 CG CD OE1 OE2 REMARK 470 HIS A 50 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 59 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 108 NE CZ NH1 NH2 REMARK 470 ARG A 112 CD NE CZ NH1 NH2 REMARK 470 MET A 120 CG SD CE REMARK 470 ASN A 149 CG OD1 ND2 REMARK 470 ASP A 150 CG OD1 OD2 REMARK 470 LYS A 162 CE NZ REMARK 470 HIS B -1 CG ND1 CD2 CE1 NE2 REMARK 470 HIS B 0 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 37 CG CD CE NZ REMARK 470 GLU B 38 CG CD OE1 OE2 REMARK 470 HIS B 50 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 62 CD CE NZ REMARK 470 ARG B 108 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 162 CG CD CE NZ REMARK 470 GLN B 172 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO B 43 OG SER B 46 1.94 REMARK 500 O ALA A 52 O HOH A 301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 12 123.64 -174.63 REMARK 500 ALA A 52 139.26 -175.43 REMARK 500 ASN A 149 -61.31 -99.02 REMARK 500 ALA A 158 -30.69 -135.55 REMARK 500 SER B 45 63.96 -54.07 REMARK 500 SER B 46 -8.73 165.07 REMARK 500 ALA B 52 100.85 178.70 REMARK 500 ALA B 158 -9.47 -148.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: TERT-BUTYL [(4S,7S,10S)-7-(CYCLOHEXYLMETHYL)-10- REMARK 630 (HYDROXYMETHYL)-5,8,13-TRIOXO-23-OXA-6,9,14,21,22- REMARK 630 PENTAAZABICYCLO[18.2.1]TRICOSA-1(22),20-DIEN-4-YL]CARBAMATE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 V66 A 203 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: BOC 5A6 GAU ALC REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue V66 A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5DGJ RELATED DB: PDB DBREF 5DG6 A 1 181 UNP Q83883 POLG_NVN68 1101 1281 DBREF 5DG6 B 1 181 UNP Q83883 POLG_NVN68 1101 1281 SEQADV 5DG6 MET A -6 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS A -5 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS A -4 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS A -3 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS A -2 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS A -1 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS A 0 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 MET B -6 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS B -5 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS B -4 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS B -3 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS B -2 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS B -1 UNP Q83883 EXPRESSION TAG SEQADV 5DG6 HIS B 0 UNP Q83883 EXPRESSION TAG SEQRES 1 A 188 MET HIS HIS HIS HIS HIS HIS ALA PRO PRO THR LEU TRP SEQRES 2 A 188 SER ARG VAL THR LYS PHE GLY SER GLY TRP GLY PHE TRP SEQRES 3 A 188 VAL SER PRO THR VAL PHE ILE THR THR THR HIS VAL VAL SEQRES 4 A 188 PRO THR GLY VAL LYS GLU PHE PHE GLY GLU PRO LEU SER SEQRES 5 A 188 SER ILE ALA ILE HIS GLN ALA GLY GLU PHE THR GLN PHE SEQRES 6 A 188 ARG PHE SER LYS LYS MET ARG PRO ASP LEU THR GLY MET SEQRES 7 A 188 VAL LEU GLU GLU GLY CYS PRO GLU GLY THR VAL CYS SER SEQRES 8 A 188 VAL LEU ILE LYS ARG ASP SER GLY GLU LEU LEU PRO LEU SEQRES 9 A 188 ALA VAL ARG MET GLY ALA ILE ALA SER MET ARG ILE GLN SEQRES 10 A 188 GLY ARG LEU VAL HIS GLY GLN SER GLY MET LEU LEU THR SEQRES 11 A 188 GLY ALA ASN ALA LYS GLY MET ASP LEU GLY THR ILE PRO SEQRES 12 A 188 GLY ASP CYS GLY ALA PRO TYR VAL HIS LYS ARG GLY ASN SEQRES 13 A 188 ASP TRP VAL VAL CYS GLY VAL HIS ALA ALA ALA THR LYS SEQRES 14 A 188 SER GLY ASN THR VAL VAL CYS ALA VAL GLN ALA GLY GLU SEQRES 15 A 188 GLY GLU THR ALA LEU GLU SEQRES 1 B 188 MET HIS HIS HIS HIS HIS HIS ALA PRO PRO THR LEU TRP SEQRES 2 B 188 SER ARG VAL THR LYS PHE GLY SER GLY TRP GLY PHE TRP SEQRES 3 B 188 VAL SER PRO THR VAL PHE ILE THR THR THR HIS VAL VAL SEQRES 4 B 188 PRO THR GLY VAL LYS GLU PHE PHE GLY GLU PRO LEU SER SEQRES 5 B 188 SER ILE ALA ILE HIS GLN ALA GLY GLU PHE THR GLN PHE SEQRES 6 B 188 ARG PHE SER LYS LYS MET ARG PRO ASP LEU THR GLY MET SEQRES 7 B 188 VAL LEU GLU GLU GLY CYS PRO GLU GLY THR VAL CYS SER SEQRES 8 B 188 VAL LEU ILE LYS ARG ASP SER GLY GLU LEU LEU PRO LEU SEQRES 9 B 188 ALA VAL ARG MET GLY ALA ILE ALA SER MET ARG ILE GLN SEQRES 10 B 188 GLY ARG LEU VAL HIS GLY GLN SER GLY MET LEU LEU THR SEQRES 11 B 188 GLY ALA ASN ALA LYS GLY MET ASP LEU GLY THR ILE PRO SEQRES 12 B 188 GLY ASP CYS GLY ALA PRO TYR VAL HIS LYS ARG GLY ASN SEQRES 13 B 188 ASP TRP VAL VAL CYS GLY VAL HIS ALA ALA ALA THR LYS SEQRES 14 B 188 SER GLY ASN THR VAL VAL CYS ALA VAL GLN ALA GLY GLU SEQRES 15 B 188 GLY GLU THR ALA LEU GLU HET CL A 201 1 HET CL A 202 1 HET V66 A 203 43 HET CL B 201 1 HETNAM CL CHLORIDE ION HETNAM V66 TERT-BUTYL [(4S,7S,10S)-7-(CYCLOHEXYLMETHYL)-10- HETNAM 2 V66 (HYDROXYMETHYL)-5,8,13-TRIOXO-23-OXA-6,9,14,21,22- HETNAM 3 V66 PENTAAZABICYCLO[18.2.1]TRICOSA-1(22),20-DIEN-4- HETNAM 4 V66 YL]CARBAMATE FORMUL 3 CL 3(CL 1-) FORMUL 5 V66 C30 H50 N6 O7 FORMUL 7 HOH *55(H2 O) HELIX 1 AA1 PRO A 2 ARG A 8 1 7 HELIX 2 AA2 HIS A 30 VAL A 32 5 3 HELIX 3 AA3 SER A 45 ILE A 47 5 3 HELIX 4 AA4 ILE A 135 CYS A 139 5 5 HELIX 5 AA5 PRO B 2 SER B 7 1 6 HELIX 6 AA6 THR B 29 VAL B 32 5 4 HELIX 7 AA7 ILE B 135 CYS B 139 5 5 SHEET 1 AA1 5 VAL A 9 PHE A 12 0 SHEET 2 AA1 5 GLY A 15 TRP A 19 -1 O GLY A 17 N THR A 10 SHEET 3 AA1 5 VAL A 24 THR A 28 -1 O ILE A 26 N PHE A 18 SHEET 4 AA1 5 PHE A 55 ARG A 59 -1 O PHE A 58 N PHE A 25 SHEET 5 AA1 5 ALA A 48 ALA A 52 -1 N ALA A 48 O ARG A 59 SHEET 1 AA2 2 GLU A 38 PHE A 39 0 SHEET 2 AA2 2 GLU A 42 PRO A 43 -1 O GLU A 42 N PHE A 39 SHEET 1 AA3 8 VAL A 72 LEU A 73 0 SHEET 2 AA3 8 TRP A 151 ALA A 160 1 O VAL A 153 N VAL A 72 SHEET 3 AA3 8 THR A 166 ALA A 170 -1 O VAL A 168 N ALA A 158 SHEET 4 AA3 8 ARG A 112 LEU A 121 -1 N GLY A 119 O VAL A 167 SHEET 5 AA3 8 LEU A 94 ILE A 109 -1 N GLY A 102 O SER A 118 SHEET 6 AA3 8 VAL A 82 LYS A 88 -1 N CYS A 83 O VAL A 99 SHEET 7 AA3 8 PRO A 142 LYS A 146 -1 O VAL A 144 N SER A 84 SHEET 8 AA3 8 TRP A 151 ALA A 160 -1 O VAL A 152 N HIS A 145 SHEET 1 AA4 5 VAL B 9 PHE B 12 0 SHEET 2 AA4 5 GLY B 15 TRP B 19 -1 O GLY B 15 N PHE B 12 SHEET 3 AA4 5 VAL B 24 THR B 27 -1 O ILE B 26 N PHE B 18 SHEET 4 AA4 5 THR B 56 PHE B 60 -1 O THR B 56 N THR B 27 SHEET 5 AA4 5 ILE B 47 GLN B 51 -1 N ALA B 48 O ARG B 59 SHEET 1 AA5 2 GLU B 38 PHE B 39 0 SHEET 2 AA5 2 GLU B 42 PRO B 43 -1 O GLU B 42 N PHE B 39 SHEET 1 AA6 8 VAL B 72 LEU B 73 0 SHEET 2 AA6 8 ASP B 150 ALA B 160 1 O VAL B 153 N VAL B 72 SHEET 3 AA6 8 VAL B 167 ALA B 170 -1 O ALA B 170 N VAL B 156 SHEET 4 AA6 8 HIS B 115 LEU B 121 -1 N GLY B 119 O VAL B 167 SHEET 5 AA6 8 LEU B 94 SER B 106 -1 N GLY B 102 O SER B 118 SHEET 6 AA6 8 VAL B 82 LYS B 88 -1 N CYS B 83 O VAL B 99 SHEET 7 AA6 8 PRO B 142 ARG B 147 -1 O VAL B 144 N SER B 84 SHEET 8 AA6 8 ASP B 150 ALA B 160 -1 O VAL B 152 N HIS B 145 LINK SG CYS A 139 C25 V66 A 203 1555 1555 1.80 SITE 1 AC1 1 ARG A 8 SITE 1 AC2 4 SER A 7 LYS A 88 CL B 201 HOH B 319 SITE 1 AC3 11 HIS A 30 GLU A 54 GLN A 110 THR A 134 SITE 2 AC3 11 PRO A 136 CYS A 139 HIS A 157 ALA A 158 SITE 3 AC3 11 ALA A 159 ALA A 160 LYS A 162 SITE 1 AC4 5 CL A 202 HOH A 320 TRP B 6 SER B 7 SITE 2 AC4 5 LYS B 88 CRYST1 37.686 67.113 127.471 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026535 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014900 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007845 0.00000 MASTER 360 0 4 7 30 0 7 6 0 0 0 30 END